Evidence map›Paper›PMID 38853848›Full record

ArticleResearch square2024

Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care.

M N Mian, V Sarovar, T Levine, A Lea, A Leibowitz, M Luu, J Flamm, C B Hare, M Horberg, K C Young-Wolff and 3 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

M N MianDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
V SarovarDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
T LevineDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
A LeaDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
A LeibowitzDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
M LuuKaiser Permanente Oakland Medical Center, Oakland, CA, USA.
J FlammKaiser Permanente Sacramento Medical Center, Sacramento, CA, USA.
C B HareKaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
M HorbergMid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, MD, USA.
K C Young-WolffDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
K T PhillipsCenter for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI, USA.
M J SilverbergDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.
D D SatreDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, Pleasanton CA.

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Implementing computerized substance use and depression screening and evidence-based treatments in an HIV primary care populationR01DA043139 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SATRE, DEREK D, SILVERBERG, MICHAEL J · 2016 to 2020
$3.2M
Mentoring alcohol use intervention research in HIV health care settingsK24AA025703 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre · 2018 to 2026
$1.8M
NIAAA NIH HHS K24 AA025703NIDA NIH HHS R01 DA043139NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

Background: While cannabis use is prevalent among people with HIV (PWH), factors associated with higher-risk use require further study. We examined factors associated with indicators risk for cannabis use disorder (CUD) among PWH who used cannabis. Methods: Participants included adult (≥18 years old) PWH from 3 HIV primary care clinics in Kaiser Permanente Northern California who reported past three-month cannabis use through the computerized Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) screening. Primary outcome was TAPS cannabis score (range 1-3), categorized as any use (1) and higher risk for CUD (≥2). Measures included sociodemographics (age, sex, race, neighborhood deprivation index [NDI]), Charlson Comorbidity Index (CCI), HIV RNA, CD4 cell counts, higher risk tobacco use (TAPS tobacco score≥2), depression, and anxiety symptoms. Unadjusted and multivariable logistic regression examined factors associated with higher risk for CUD. Results: Of the complete sample ( Conclusions: Black race, anxiety and tobacco use, but not HIV clinical markers, were associated with higher risk for CUD among PWH. Clinical efforts to screen and provide interventions for preventing CUD alongside anxiety and tobacco use among PWH should be evaluated.

Indexed as

cannabisHIVmarijuanaprimary care

Identifiers

PMID38853848
PMCPMC11160885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.